New BD LSRFortessa Cell Analyzer delivers maximal sensitivity and resolution for multicolor applications

Building upon its powerful BD™ LSR cell analyzer platform, BD Biosciences launched today a new off-the-shelf BD LSRFortessa™ System, which uses up to four lasers -- blue, red, violet and UV -- that enable the detection of up to 18 colors simultaneously.

This new system occupies a 30''x 36" benchtop footprint, allowing researchers to maximize utilization of their lab space, without sacrificing system power. The system includes a number of innovative technologies, including novel collection optics that reduce excitation losses and improve light collection efficiency. The result is optical efficiency that delivers maximal sensitivity and resolution for multicolor applications.

"Our quest is to enhance cellular analysis by making multicolor flow cytometry analysis more powerful and accessible to life science researchers," said James Glasscock, President, Cell Analysis, BD Biosciences. "This new BD LSRFortessa System is a perfect example of how we are offering researchers powerful, flexible, high-performance tools that will meet their needs today and tomorrow."

As researchers' needs grow, the new BD LSRFortessa System may be upgraded with additional or new lasers through the special order program to meet their precise assay requirements. This system is complemented by the special order BD LSRFortessa Cell Analyzer, which was launched in June 2009. The special order BD LSRFortessa is customer configurable with up to five lasers, as well as a choice of more than 11 wavelengths, 30 positional choices for detectors, and multiple power options to meet researchers' exact specifications.

The BD LSRFortessa System is the newest addition to the line of BD™ LSR cell analyzers – the preferred tool of life science researchers worldwide working in core, academic, pharmaceutical and biotechnology laboratories.  


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space